Aarkstore - Papillary Thyroid Cancer-Pipeline Insights, 2014

1
Papillary Thyroid Cancer-Pipeline Insights,
2014
Category Pharmaceuticals Healthcare

• Browse Complete Report -
• http//www.aarkstore.com/healthcare/77315/-papilla
  ry-thyroid-cancer-pipeline-insights-2014

2
Summary

• DelveInsights, Papillary Thyroid Cancer-Pipeline
  Insights, 2014, report provides comprehensive
  insights about pipeline drugs across this
  indication. A key objective of the report is to
  establish the understanding for all the pipeline
  drugs that fall under Papillary Thyroid Cancer.
  This report provides information on the
  therapeutic development based on the Papillary
  Thyroid Cancer dealing with all the pipeline
  drugs, comparative analysis at various stages
  covering Filed, Phase III, Phase II, Phase I, IND
  filed, Preclinical, Discovery and unknown stages,
  therapeutics assessment by monotherapy and
  combination products and molecule type drug
  information. The report also covers the companies
  information involved in the therapeutic
  development of the products. It also has
  highlighted the discontinued and dormant products.

3
Summary

• Data Sources
• The report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by
  DelveInsight team of industry experts.Secondary
  sources information and data has been collected
  from various printable and non-printable sources
  like search engines, News websites, Government
  Websites, Trade Journals, White papers,
  Magazines, Trade associations, Books, Industry
  Portals, Industry Associations and access to
  available databases.Note This report requires
  certain updates. We have all the information
  available but require 3 business days to complete
  the process and ensure it is as up-to-date as
  possible. Certain sections in the report may be
  removed or altered based on the availability and
  relevance of data for the indicated Indication.

4
Summary

• Scope 
• The report provides a snapshot of the global
  therapeutic landscape of Papillary Thyroid
  CancerThe report provides pipeline products
  under drug profile section which includes product
  description, MOA, licensors collaborators,
  development partner and chemical
  informationCoverage of the Papillary Thyroid
  Cancer pipeline on the basis of target, MOA,
  route of administration, technology involved and
  molecule typeThe report reviews key players
  involved in the therapeutics development for
  Papillary Thyroid Cancer and also provide company
  profilingThe report also gives the information
  of dormant and discontinued pipeline
  projects Pipeline products coverage based on
  various stages of development ranging from
  preregistration till discovery and undisclosed
  stages Provides pipeline assessment by
  monotherapy and combination therapy products,
  stage of development and molecule type

5
Summary

• Reasons to buyComplete Pipeline intelligence
  and complete understanding over therapeutics
  development for Papillary Thyroid Cancer
• Identify the relationship between the drugs and
  use it for target finding, drug repurposing, and
  precision medicine.
• Devise corrective measures for pipeline projects
  by understanding Papillary Thyroid Cancer
  pipeline depth and focus of Indication
  therapeutics
• Developing strategic initiatives to support your
  drug development activities.
• Optimize your portfolio and keep you in touch
  with the rapidly changing pharmaceutical markets,
  and make the best decisions for your business.

6
Summary

• Develop and design in licensing and out licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies
• Modify the therapeutic portfolio by identifying
  discontinued projects and understanding the
  factors that drove them from pipeline
• Gaining a Full Picture of the Competitive
  Landscape for Evidence based Decisions
• You can order full Report with TOC and for Sample
  page visit _at_
• http//www.aarkstore.com/healthcare/77315/-papill
  ary-thyroid-cancer-pipeline-insights-2014

7
Table of Content

• Papillary Thyroid Cancer OverviewPapillary
  Thyroid Cancer Pipeline TherapeuticsPapillary
  Thyroid Cancer Therapeutics under Development by
  Companies Papillary Thyroid Cancer Late Stage
  Products (Filed and Phase III)Comparative
  Analysis Papillary Thyroid Cancer Mid Clinical
  Stage Products (Phase II)Comparative
  Analysis Papillary Thyroid Cancer Early Clinical
  Stage Products (Phase I and IND
  Filed)Comparative Analysis Papillary Thyroid
  Cancer Discovery and Pre-Clinical Stage
  Products Comparative Analysis 

8
Table of Content

• Drug Candidate ProfilesPapillary Thyroid Cancer
  Therapeutics Assessment Assessment by
  Monotherapy Products Assessment by Combination
  Products Assessment by Route of
  Administration Assessment by Molecule
  Type Papillary Thyroid Cancer Discontinued
  Products Papillary Thyroid Cancer Dormant
  ProductsCompanies Involved in Therapeutics
  Development for Papillary Thyroid
  Cancer Appendix Methodology Contact
  Us Disclaimer

9
List of Tables

• Number of Products under Development for
  Papillary Thyroid Cancer, 2014Number of Products
  under Development by Companies Comparative
  Analysis by Late Clinical Stage Products (Filed
  and Phase III), 2014Comparative Analysis Mid
  Clinical Stage Products (Phase II),
  2014Comparative Analysis Early Clinical Stage
  Products (Phase I and IND Filed),
  2014Comparative Analysis Discovery and
  Pre-Clinical Stage Products, 2014Drug Candidates
  ProfilesPapillary Thyroid Cancer Assessment by
  Monotherapy Products Papillary Thyroid Cancer
  Assessment by Combination Products 

10
List of Tables

• Papillary Thyroid Cancer Assessment by Route of
  Administration Papillary Thyroid Cancer
  Assessment by Stage and Route of
  Administration Papillary Thyroid Cancer
  Assessment by Molecule Type Papillary Thyroid
  Cancer Assessment by Stage and Molecule
  Type Papillary Thyroid Cancer Therapeutics
  Discontinued Products Papillary Thyroid Cancer
  Therapeutics Dormant ProductsProducts under
  Development by Companies, 2014

11
List of Figures

• Number of Products under Development for
  Papillary Thyroid Cancer, 2014Late Clinical
  Stage Products (Filed and Phase III), 2014Mid
  Clinical Stage Products (Phase II), 2014Early
  Clinical Stage Products (Phase I and IND Filed),
  2014Discovery and Pre-Clinical Stage Products,
  2014Papillary Thyroid Cancer Assessment by
  Monotherapy Products Papillary Thyroid Cancer
  Assessment by Combination Products Papillary
  Thyroid Cancer Assessment by Route of
  Administration Papillary Thyroid Cancer
  Assessment by Stage and Route of
  Administration Papillary Thyroid Cancer
  Assessment by Molecule Type Papillary Thyroid
  Cancer Assessment by Stage and Molecule Type

12
Related Reports

• 2015 Worldwide Medical Laboratories
  Industry-Industry Market Report
• 2015 Worldwide Pharmaceutical Preparation Mfg.
  Industry-Industry Market Report
• OncoPlex Diagnostics - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• MetaStat, Inc. - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Advanced Cell Diagnostics, Inc. - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• Ascension Health - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Accretive Health, Inc. (ACHI) - Strategic SWOT
  Analysis Review
• Jazz Pharmaceuticals plc (JAZZ) - Financial and
  Strategic SWOT Analysis Review
• Pharmstandard (PHST) - Financial and Strategic
  SWOT Analysis Review
• GLG Life Tech Corporation (GLG) - Financial and
  Strategic SWOT Analysis Review

13

• Papillary Thyroid Cancer-Pipeline Insights, 2014
• Published Dec. 2014 60 Pages
• DelveInsights, Papillary Thyroid Cancer-Pipeline
  Insights, 2014, report provides comprehensive
  insights about pipeline drugs across this
  indication.
  Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news